Picture of HLB BioStep Co logo

278650 HLB BioStep Co Balance Sheet

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Annual balance sheet for HLB BioStep Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
R2021
December 31st
R2022
December 31st
Period Length:
Source:PROSPECTUSAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsInterim Report
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments3,83916,20214,91010,39397,045
Net Total Accounts Receivable
Net Total Receivables3,7896,9468,82910,15310,148
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets16,25429,22828,57931,178112,424
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment18,38223,14626,22639,86739,626
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets43,74161,53174,21594,626172,187
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities10,21712,09015,37916,58212,775
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities23,07219,66720,57230,038101,909
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Other Equity
Total Equity20,66941,86453,64364,58770,278
Total Liabilities & Shareholders' Equity43,74161,53174,21594,626172,187
Total Common Shares Outstanding
Total Preferred Shares Outstanding